It is a systemic disease that emerges from complex interactions between our genetics, diet, lifestyle, immune function, and environmental exposures.

Patients with systemic lupus erythematosus with a history of cutaneous lupus erythematosus are more likely to have high ...

Objectives Cardiac amyloidosis (CA) is a rare and underdiagnosed disease associated with a high mortality rate. Although, in ...

People with SLE commonly have systemic or “constitutional” symptoms such as fatigue, fever and generalized aching. The ...

A lack of racial diversity in clinical trials is a long-standing, well-documented problem that contributes to the stark health inequalities that have been brought into sharp focus by COVID-19.

Intravenous belimumab plus SOC vs placebo plus SOC was not linked to an increased risk for infection among patients with SLE.

Three scientists have been awarded research grants through Chiesi’s ‘Find For Rare’ programme to advance early-stage ...

Merck Presents Positive Phase 2 Data for Enpatoran Demonstrating Reduction in Disease Activity in Patients with Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE) with ...

A retrospective analysis of US medical records of people aged 65-95 years finds those with psoriasis on systemic therapies have a lower ... for Alzheimer’s disease, 0.65 (0.51-0.83) for ...